Sign Up Today and Learn More About Sidewinder Therapeutics Stock
Invest in or calculate the value of your shares in Sidewinder Therapeutics or other pre-IPO companies through EquityZen's platform.
Sidewinder Therapeutics Stock
Sidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases.
About Sidewinder Therapeutics Stock
Founded
2023
Headquarters
San Diego, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Sidewinder Therapeutics Press Mentions
Stay in the know about the latest news on Sidewinder Therapeutics
The biggest biotech funding rounds in April 2026
labiotech • May 08, 2026
Two New Takes on Making a Type of Targeted Cancer Therapy Even Better
medcitynews • Apr 16, 2026
OrbiMed’s Sidewinder slides toward clinic with $137M series B for antibody-drug conjugates
sdbn • Apr 14, 2026
ADC biotech Sidewinder collects $137M for bispecific approach
sdbn • Apr 14, 2026
The Week’s 10 Biggest Funding Rounds: SiFive Leads With $400M For Custom Chip Designs As Aviation, Biotech And Defense Startups Also Raise Big
news • Apr 10, 2026
Sidewinder Therapeutics Management
Leadership team at Sidewinder Therapeutics
Board Member
Michal Silverberg
Co-Founder
Ryan Corcoran
Join now and verify your accreditation status to gain access to:
- Sidewinder Therapeutics Current Valuation
- Sidewinder Therapeutics Stock Price
- Sidewinder Therapeutics Management
- Available deals in Sidewinder Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Sidewinder Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Sidewinder Therapeutics Revenue and Financials
- Sidewinder Therapeutics Highlights
- Sidewinder Therapeutics Business Model
- Sidewinder Therapeutics Risk Factors
- Sidewinder Therapeutics Research Report from SACRA Research
Trading Sidewinder Therapeutics Stock
How to invest in Sidewinder Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Sidewinder Therapeutics through EquityZen funds. These investments are made available by existing Sidewinder Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Sidewinder Therapeutics stock?
Shareholders can sell their Sidewinder Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 450K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 53K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."